# Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

> **NCT00034840** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 490 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** telmisartan, valsartan

## Key facts

- **NCT ID:** NCT00034840
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 490 (—)
- **Last updated:** 2013-11-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034840, "Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00034840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*